Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department;Intensidad de anticoagulación con warfarina y el riesgo de eventos adversos en pacientes que se presentan al departamento de emergencias

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages 881-887

  Anthony, Crystal J ^a,b   Karim, Saleema ^c   Ackroyd Stolarz, Stacy ^d,e   Fry, Amy ^a   Murphy, Nancy G ^a,e,f   Christie, Russell ^g   Zed, Peter J ^a,h  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Government of Nova Scotia Emergency Health Services   (Canada)

^d Dalhousie University ^*  (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f IWK HEALTH CENTRE   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adverse event; Emergency medicine; Hemorrhage; International normalized ratio; Patient safety; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IPRATROPIUM BROMIDE; IRON; LEVOTHYROXINE; PARACETAMOL; POTASSIUM; PREDNISONE; PROTON PUMP INHIBITOR; TIOTROPIUM BROMIDE; VITAMIN D; WARFARIN;

AGED; ALLERGY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COMPARTMENT SYNDROME; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOPERICARDIUM; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOCULAR HEMORRHAGE; LABORATORY TEST; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MEDICINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROPERITONEAL HEMORRHAGE; RISK FACTOR; SPINAL CORD HEMORRHAGE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; CANADA; DIET; FEMALE; HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM; TRAUMA CENTERS; VITAMIN K; WARFARIN;

EID: 79960803040     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P670     Document Type: Article

References (26)

1. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists. Chest 2008;133(suppl):160S-98S. DOI 10.1378/chest.08-0670
2. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2008;133(suppl):454S-545S. DOI 10.1378/chest.08-0658
3. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation. Chest 2008;133(suppl):546S-92S. DOI 10.1378/chest.08-0678
4. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease. Chest 2008;133(suppl):593S- 629S. DOI 10.1378/chest.08-0724
5. Jones M, McEwan P, Morgan CL, et al. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with nonvalvar atrial fibrillation: a record linkage study in a large British population. Heart 2005;91:472-7.DOI 10.1136/hrt.2004.042465
6. Watzke HH, Forberg E, Svolba G, et al. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000;83:661-5.
7. Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007;27:1237-1247. DOI 10.1592/phco.27.9.1237
8. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natu ral substances, and foods. J Clin Pharmacol 2005;45:127-32.DOI 10.1177/0091270004271404
9. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of war farin and its drug and food interactions. Arch Intern Med 2005;165: 1095-106.
10. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
11. van Walraven C, Austin PC, Oake N, et al. The effect of hospitalization on oral anticoagulant control: a population-based study. Thromb Res 2007;119:705-14. DOI 10.1016/j.thromres.2006.05.017
12. Tang EOYL, Lai CSM, Lee KKC, Wong RS, Cheng G, Chan TYK. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother 2003;37:34-9. DOI 10.1345/aph.1A198
13. Biscup-Horn PJ, Streiff MB, Ulbrich TR, Nesbit TW, Shermock KM. Impact of an inpatient anticoagulation management service on clinical outcomes. Ann Pharmacother 2008;42:777-82. DOI 10.1345/aph.1L027
14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7.
15. Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoag-ulation care in patients discharged from a pharmacist-managed anticoag-ulation clinic after stabilization of warfarin therapy. Pharmacotherapy 2008;28:20-6. DOI 10.1592/phco.28.1.20
16. van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metare-gression. Chest 2006;129:1155-66. DOI 10.1378/chest.129.5.1155
17. Muszkat M, Blotnik S, Elami A, Krasilnikov I, Caraco Y. Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions. Clin Ther 2007;29:427-37. DOI 10.1016/S0149-2918(07)80081-6
18. Odén A, Fahlén M, Hart RG. Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res 2006;117:493-9. DOI 10.1016/j.thromres.2004.11.025
19. White HD, Gruber M, Feyzi J, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 2007;167:239-45.
20. Oake N, Jennings A, Forster A, et al. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ 2008;179:235-44.DOI 10.1503/cmaj.080171
21. Budnitz DS, Shebab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147:755-65.
22. Newman DH, Zhitomirsky I. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department. Ann Emerg Med 2006;48:182-9.DOI 10.1016/j.annemergmed.2005.12.010
23. Habib G, Nashashibi M, Khateeb A, et al. Excessive prolongation of pro- thrombin time among patients treated with warfarin and admitted to the emergency room. Eur J Intern Med 2008;19:129-34. DOI 10.1016/j.ejim.2007.08.006
24. Schulman S, Kearon C on behalf of the subcommittee on control of anti-coagulation of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Scientific and Standardization Committee Communication. J Thromb Haemost 2005;3:692-4.
25. Oake N, Fergusson DA, Forster AJ, van Walraven C. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ 2007;176:1589-94. DOI 10.1503/cmaj.061523
26. Zed PJ, Abu-Laban RB, Balen RB, et al. Incidence, severity and pre-ventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-9. DOI 10.1503/cmaj.071594